Pharmacogenetics of Torasemide and Spironolactone in Hypertension Treatment

NCT06413082 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Genetic Predisposition
Drug Effect

Interventions

DRUG: Torasemide
DRUG: Spironolactone

Sponsor

Ospedale San Raffaele